Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
the standard route for this molecule is oral
Benefits include building muscle mass, preventing muscle wasting, building bone mass, helping with growth, managing blood sugar levels and protecting against neurological disorders
Overall, constipation in patients taking GLP-1 receptor agonists is common, predictable, and manageable
US$ 28.02
US$ 29.48
US$ 27.20
US$ 20.84
US$ 23.75
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991427-c2c4d692054b4ff6933f01fc6c5be06c.jpg)
